publication . Article . 2005

Physicochemical and biological studies of a new erythromycin derivate - erythromycin folate

Manna, P.K.; Kumaran, V.; Mohanta, G.P.;
Open Access English
  • Published: 01 Jan 2005
  • Publisher: Universidad de Granada, Facultad de Farmacia
  • Country: Spain
Abstract
A new derivative of erythromycin, Erythromycin folate was prepared and its physicochemical and biological properties were evaluated. The derivative has good solubility in methanol, ethanol and propylene glycol. The partition coefficient values of 1.12 and 1.10 in chloroform/water and octanol/water systems respectively indicate that the derivative will probably distribute well in vivo. The in vitro potency of the derivative, 716 μg/mg, is higher than the existing derivatives like erythromycin estolate, erythromycin stearate, erythromycin ethyl succinate, erythromycin gluceptate, and erythromycin lactobionate. The in vitro Minimum Inhibitory Concentrations are les...
Read more
Subjects
free text keywords: Folato de eritromicina, Erythromycin folate, Actividad antimicrobiana in vitro, In vitro antimicrobial activity, Concentración sérica in vivo, In vivo serum concentration, Parámetros farmacocinético, Pharmacokinetic parameters
Related Organizations
Download from
Repositorio Institucional Universidad de Granada
Article . 2005
Provider: Repositorio Institucional Universidad de Granada
24 references, page 1 of 2

diante la fórmula siguiente: 1. British National Formulary 46 British Medical Association, Royal Pharmaceutical Society of Great Britain, Pharmaceutical

Press, 2003; 274 - 275 2. American Society of Health System Pharmacist, American Hospital Formulary Service, MD, America, 2001; 3316 - 3318 3. Mycek MJ, Harvey RA, Champe PC. in: Pharmacology. Harvey RA, Champe PC. ed., Lipincott Williams and Wilkins,

New York, 2000; 317 - 321. 4. Haslet C, Edwin R, Chilvers R, John A, Hunter A, Boon NA. in: Principles and Practice of Medicine. Davidson, ed.,

Churchill Livingstone, London, 2000; 344. 5. Laurence DR, Bennet AN, Brown NJ. in; Clinical Pharmacology. D. R. Laurence ed., Churchill Livingstone, 1997; 208

- 209. 6. Garrod LP, Lambert HP, Grady FO. in; Antibiotics and Chemotherapy. 7. Bray and Stephens, Preparation of erythromycin estolate (ester salt). U.S. Patent 3,000,874 (1961 to Lilly Laboratories,

U.S.A). 8. Walasek OF, Preparation of erythromycin stearate, (salt). U.S. Patent 2,881,163 (1959 to Abbott, Laboratories, U.S.A). 9. Shepher, Preparation of erythromycin glucoheptonate (salt). U.S. Patent 2,852,429 (1958 to Lilly Laboratories, U.S.A). 10. Hoffhine, Preparation of erythromycin lactobionate (salt). U.S. Patent 2,761,859 (1956 to Abbott, Laboratories, U.S.A). 11. Stephens VC, Preparation of erythromycin propionate. U.S. Patent 2,993,833 (1961 to Lilly, Laboratories, U.S.A). 12. Morvolla MLA, Preparation of erythromycin acistrate (ester prodrug). Belgian Patent, 901,411 (1985 to Orion Yhtyma

Oy). 13. Honkanen EJ, Preparation of erythromycin acistrate (ester prodrug). U.S. Patent 4,599,326 (1986 to Orion Ohiama). 14. Chun AHC, Seitz JA. Drug Bioavailability Information and its Utility. J. Am. Pharm. Ass. 1974; 14: 407 - 414. 15. Chun AHC, Seitz JA, Pharmacokinetics and Biological Availability of Erythromycin. Infection. 1977; 5 (suppl): 14 -

22. 16. Mathur CE, Austin KC, Philpot CR, McDonald PJ. Absorption and oral bioavailability of erythromycin. Br. J. Clin.

Pharmac. 1981; 12: 131 - 140. 17. Czeizel AE, Dudas I. Prevention of first occurrence of neural tube defects by preconceptional vitamin supplementation.

N Engl. J. Med. 1992; 327: 1831 - 1835. 18. Bery RJ, Li Z, Errickson J. Prevention of neural - tube defects with folic acid in China. N Engl. J. Med. 1999; 341:

1485 - 1490. 19. Clarke R, Robert J. Foliate, Vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Archives

of Neurology. 1998; 55: 1449 - 1455. 20. Ali M, Killian R. Homocysteine: an emerging age related cardiovascular risk factor. Geriatrics. 1999; 55: 41 - 51. 21. Hultberg B, Agardh CD, Agardh E, Lovestam Adrian M. Poor metabolic control early age onset, marginal folate deficiency

Lab. Invest. 1997; 57: 595 - 600. 22. Dutta SK, Basu SK. Preparation of Erythromycin Aldobionate. Indian patent No. 142584 to Jadavpur University, Calcutta,

India 1977. 23. Dutta SK, Basu SK. Preparation of Erythromycin Aldobionate. US Patent No. 4137378 to Jadavpur University, Calcutta,

India 1979. 24. Marsh JR, Weiss PJ. Solubility of Antibiotics in 26 Solvents. J. Assoc. Offic. Anal. Chem. 1977; 50 (2): 457 - 462. 25. Grove DC, Randall UA. in: Assay methods of Antibiotics - A laboratory manual, Medical encyclopedia. Welch H, Marti-

24 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue